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Development of erythematous scaly 
lesions in a cervical surgical scar
Case 
A woman, 58 years of age, presented 
with a scaly rash along a surgical scar. 
She had a history of type 2 diabetes 
mellitus, hypertension and psoriasis, 
which had been followed up by a 
dermatologist since adolescence. 
Previous therapies for the psoriasis 
included topical therapy, phototherapy, 
methotrexate and acitretin. Because of a 
lack of improvement on these therapies, 
she started etanercept 50 mg/week, 
experiencing an excellent response. 
The patient was diagnosed with 
squamous cell carcinoma of the tongue 
after 12 months of etanercept therapy. 
Etanercept was ceased and the patient 
underwent right partial glossectomy 
and selective cervical lymph node 
dissection. Ten weeks after surgery, she 
developed a 1–3 cm erythematous, non-
pruritic, painless, scaly lesion located 
solely at the cervical surgical scar 
(Figure 1A, B).
Question 1
What is the most likely diagnosis in this 
patient?
Question 2
What differential diagnoses would you 
consider?
Question 3
In which skin disorders can this 
phenomenon also occur?
Question 4
What therapeutic measures would you 
recommend?
Answer 1
Based on the patient´s history and 
the appearance of the lesions, the 
most likely diagnosis is psoriasis 
located solely at the surgical scar. 
The development of psoriatic lesions 
on uninvolved skin of patients with 
psoriasis as a consequence of trauma 
can occur and is called Koebner 
phenomenon (KP). The appearance 
of lesions typically takes 10–20 days 
following the trauma. Not all kinds of 
trauma lead to the phenomenon, and 
lesions do not follow any anatomical 
preference as they can occur in 
areas that are usually spared by the 
disease.1 The Koebner response usually 
follows mechanical or thermal trauma, 
dermatoses, or allergic or irritant 
reactions.2 Its pathogenesis is unknown, 
although several theories have been 
proposed. The impact of KP varies 
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Figure 1. Erythematous scaly lesions located at 
the cervical scar
according to the underlying disease. A 
possible explanation for why psoriasis 
preferentially occurs at scar sites is 
that changes in vascularity, presence 
of microscarring or chronic mast cell 
infiltration may induce memory of an 
inflammatory event.1 However, the 
complex mechanisms that trigger the 
phenomenon are not fully understood.
Answer 2
Psoriasis lesions may sometimes 
be confused with eczema, although 
eczema is usually more pruritic and 
has less thick scaling than psoriasis.3 
Fungal infections can look very similar, 
especially when compared to partially 
resolved psoriasis, which typically 
shows central clearing. Skin tumours 
can also mimic psoriasis lesions and 
should be suspected in cases of an 
isolated lesion similar to a plaque of 
psoriasis that slowly enlarges despite 
treatment.4
In the case of this patient, the history 
of neck surgical intervention cannot 
be overlooked; therefore, another 
differential diagnosis is surgical wound 
infection. However, this hypothesis is 
less likely because the patient did not 
present with fever, skin swelling, fluid 
collection or purulent discharge. 
Answer 3
Other skin diseases can arise at sites 
of cutaneous injury, resulting in an 
isomorphic response similar to that 
seen with psoriasis.5 KP can be divided 
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into four categories depending on the 
mechanism of trauma:6
• True Koebnerisation – KP is reproducible 
in all patients following a variety of 
insults (except secondary to infectious 
or allergenic agents) and is often seen 
in patients with psoriasis, lichen planus 
and vitiligo.
• Pseudo-Koebnerisation – skin 
breakdown or the seeding of an 
infectious agent in the surrounding 
tissue induces KP. This is often seen 
in patients with verrucae, impetigo or 
molluscum contagiosum infection.
• Occasional KP – some criteria for 
KP are present, such as Darier’s 
disease, erythema multiforme or lupus 
erythematosus.
• Trauma-induced processes – the lesions 
have a questionable connection to 
trauma, such as pemphigus vulgaris.
Answer 4
Koebner lesions are treated in the same 
way as the associated dermatosis, in 
this case psoriasis. Cosmetic surgery 
or therapeutic proceedings should, if 
possible, be made while the disease is 
quiescent.1
Key points
• KP is the development of isomorphic 
pathological lesions in the traumatised, 
uninvolved skin of patients who have 
active cutaneous diseases.
• KP is often associated with psoriasis, 
lichen planus and vitiligo.
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